1. Home
  2. VTAK

VTAK

Catheter Precision Inc.

Health Care

Medical/Dental Instruments

Nasdaq

as 04-19-2024 4:00pm EST

$
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Catheter Precision Inc is engaged in design, manufacture and sale of new and innovative medical technologies primarily focused in the field of cardiac electrophysiology, or EP. The Company's primary product is the View into Ventricular Onset System (VIVO or VIVO System) which is a non-invasive imaging system that offers 3D cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients with structurally normal hearts prior to EP procedures. The VIVO system has achieved a CE Mark allowing it to be commercialized in the European Union and has been placed at several hospitals in Europe. Its newest product, the Surgical Vessel Closing Pressure Device (LockeT), is a suture retention device indicated for wound healing by distributing suture tension.

Founded: 2002 Country:
United States
United States
Employees: N/A City: FORT MILL
Market Cap: 3.4M IPO Year: 2018
Target Price: N/A AVG Volume (30 days): 49.7K
Analyst Decision: N/A Number of Analysts: N/A
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -12.99 EPS Growth: N/A
52 Week Low/High: $0.34 - $1.63 Next Earning Date: 05-31-2024
Revenue: $442,000 Revenue Growth: 3057.14%
Revenue Growth (this year): 637.1% Revenue Growth (next year): 177.13%

Share on Social Networks: